ONC:CA Stock

With the thought of a Phase III cancer trial on the horizon Leede Jones Gable analyst Douglas W. Loe... Read More

The start of a Phase 2 trial is a key step for Oncolytics Biotech (Oncolytics Biotech Stock Quote, C... Read More

Alberta-based biologics developer Oncolytics Biotech (Oncolytics Biotech Stock Quote, Chart, News TS... Read More

Compared to its oncology drug peers, Canadian cancer biologics developer Oncolytics Biotech (Oncolyt... Read More

Echelon Wealth Partners analyst Douglas Loe says price softness in cancer biologics developer Oncoly... Read More